Aligos Therapeutics Inc
NASDAQ:ALGS
Shareholder Yield
Current shareholder yield for 
ALGS is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
ALGS Price
Aligos Therapeutics Inc
| Average Annual Return | -10.86% |
| Standard Deviation of Annual Returns | 94.54% |
| Max Drawdown | -100% |
| Market Capitalization | 44.4m USD |
| Shares Outstanding | 6 150 000 |
| Percentage of Shares Shorted | 4.59% |
ALGS Return Decomposition
Main factors of price return
Stock Splits
ALGS's latest stock split occurred on Aug 19, 2024
The company executed a 1-for-25 stock split, meaning that for every 25 shares held, investors received 1 new share.
Before the split, ALGS traded at 0.525 per share. Afterward, the share price was about 14.25.
The adjusted shares began trading on Aug 19, 2024. This was the only stock split in ALGS's history.
